Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 41, 2010, Pages 17763-17767

  Vlassenko, Andrei G ^a   Vaishnavi, S Neil ^a   Couture, Lars ^a   Sacco, Dana ^a   Shannon, Benjamin J ^a   Mach, Robert H ^a   Morris, John C ^a   Raichle, Marcus E ^a   Mintun, Mark A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Default mode network; Positron emission tomography

Indexed keywords

AMYLOID BETA PROTEIN; CARBON 11; PITTSBURGH COMPOUND B;

ADULT; AGED; ALZHEIMER DISEASE; ANAEROBIC GLYCOLYSIS; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; COGNITION; FEMALE; GLUCOSE UTILIZATION; HUMAN; MALE; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; ALZHEIMER DISEASE; AMYLOID; BRAIN; FEMALE; GLUCOSE; GLYCOLYSIS; HUMANS; MALE; OXYGEN; POSITRON-EMISSION TOMOGRAPHY;

EID: 77958453314     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1010461107     Document Type: Article

References (79)

1. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430:631-639.
2. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-356. (Pubitemid 34790756)
3. Hulette CM, et al. (1998) Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 57:1168-1174.
4. Morris JC, Price AL (2001) Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 17:101-118.
5. Klunk WE, et al. (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55:306-319.
6. Fagan AM, et al. (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59:512-519.
7. Mintun MA, et al. (2006) [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease. Neurology 67:446-452.
8. Raichle ME, et al. (2001) A default mode of brain function. Proc Natl Acad Sci USA 98:676-682.
9. Buckner RL, et al. (2005) Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25:7709-7717.
10. Raichle ME, Snyder AZ (2007) A default mode of brain function: A brief history of an evolving idea. Neuroimage 37:1083-1090, discussion 1097-1099.
11. Buckner RL, Andrews-Hanna JR, Schacter DL (2008) The brain's default network: Anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124:1-38.
12. Vaishnavi SN, et al. (2010) Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci USA, 10.1079/pnas1010459107.
13. Raichle ME, Posner JB, Plum F (1970) Cerebral blood flow during and after hyperventilation. Arch Neurol 23:394-403.
14. Boyle PJ, et al. (1994) Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans. J Clin Invest 93:529-535.
15. Powers WJ, et al. (2007) Selective defect of in vivo glycolysis in early Huntington's disease striatum. Proc Natl Acad Sci USA 104:2945-2949.
16. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324:1029-1033.
17. Bolanos JP, Delgado-Esteban M, Herrero-Mendez A, Fernandez-Fernandez S, Almeida A (2008) Regulation of glycolysis and pentose-phosphate pathway by nitric oxide: Impact on neuronal survival. Biochim Biophys Acta 1777 (7-8):789-793.
18. Vaughn AE, Deshmukh M (2008) Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol 10:1477-1483.
19. Jolivet R, Magistretti PJ, Weber B (2009) Deciphering neuron-glia compartmentalization in cortical energy metabolism. Front Neuroenergetics 1:1-10.
20. Minoshima S, Cross DJ, Foster NL, Henry TR, Kuhl DE (1999) Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications. Ann N Y Acad Sci 893:350-352.
21. Minoshima S, Foster NL, Kuhl DE (1994) Posterior cingulate cortex in Alzheimer's disease. Lancet 344:895.
22. Cohen AD, et al. (2009) Basal cerebral metabolism may modulate the cognitive effects of Abetainmild cognitive impairment:Anexampleofbrain reserve. J Neurosci 29:14770-14778.
23. Rabinovici GD, et al. (2010) Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 133:512-528.
24. Reivich M, et al. (1979) The [18F fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44:127-137.
25. Phelps ME, et al. (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol 6:371-388.
26. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD (1994) Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia 5:36-41. (Pubitemid 24022692)
27. Minoshima S, et al. (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42:85-94.
28. Fox PT, Raichle ME, Mintun MA, Dence C (1988) Nonoxidative glucose consumption during focal physiologic neural activity. Science 241:462-464.
29. Madsen PL, et al. (1995) Persistent resetting of the cerebral oxygen/glucose uptake ratio by brain activation: Evidence obtained with the Kety-Schmidt technique. J Cereb Blood Flow Metab 15:485-491.
30. Warburg O (1939) The Metabolism of Tumors (Constable & Company, London); trans Dickens F.
31. Brand KA, Hermfisse U (1997) Aerobic glycolysis by proliferating cells: A protective strategy against reactive oxygen species. FASEB J 11:388-395.
32. Elston GN, Oga T, Fujita I (2009) Spinogenesis and pruning scales across functional hierarchies. J Neurosci 29:3271-3275.
33. Tononi G, Cirelli C (2006) Sleep function and synaptic homeostasis. Sleep Med Rev 10:49-62.
34. Marder E, Prinz AA (2002) Modeling stability in neuron and network function: The role of activity in homeostasis. Bioessays 24:1145-1154.
35. Altman DI, Perlman JM, Volpe JJ, Powers WJ (1993) Cerebral oxygen metabolism in newborns. Pediatrics 92:99-104.
36. Powers WJ, Rosenbaum JL, Dence CS, Markham J, Videen TO (1998) Cerebral glucose transport and metabolism in preterm human infants. J Cereb Blood Flow Metab 18:632-638.
37. Settergren G, Lindblad BS, Persson B (1976) Cerebral blood flow and exchange of oxygen, glucose, ketone bodies, lactate, pyruvate and amino acids in infants. Acta Paediatr Scand 65:343-353.
38. Chugani HT, Phelps ME, Mazziotta JC (1987) Positron emission tomography study of human brain functional development. Ann Neurol 22:487-497. (Pubitemid 17164772)
39. Raichle ME, Mintun MA (2006) Brain work and brain imaging. Annu Rev Neurosci 29:449-476.
40. Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 91:10625-10629.
41. Mercer RW, Dunham PB (1981) Membrane-bound ATP fuels the Na/K pump. Studies on membrane-bound glycolytic enzymes on inside-out vesicles from human red cell membranes. J Gen Physiol 78:547-568.
42. Okamoto K, Wang W, Rounds J, Chambers EA, Jacobs DO (2001) ATP from glycolysis is required for normal sodium homeostasis in resting fast-twitch rodent skeletal muscle. Am J Physiol Endocrinol Metab 281:E479-E488.
43. Campbell JD, Paul RJ (1992) The nature of fuel provision for the Na+,K(+)-ATPase in porcine vascular smooth muscle. J Physiol 447:67-82.
44. Wu K, Aoki C, Elste A, Rogalski-Wilk AA, Siekevitz P (1997) The synthesis of ATP by glycolytic enzymes in the postsynaptic density and the effect of endogenously generated nitric oxide. Proc Natl Acad Sci USA 94:13273-13278.
45. Lipton P, Robacker K (1983) Glycolysis and brain function: [K+]o stimulation of protein synthesis and K+ uptake require glycolysis. Fed Proc 42:2875-2880. (Pubitemid 13007096)
46. McGilvery RW, Goldstein GW (1983) Biochemistry: A Functional Approach (Saunders, Philadelphia).
47. Olney JW (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164:719-721.
48. Olney JW (2003) Excitotoxicity, apoptosis and neuropsychiatric disorders. Curr Opin Pharmacol 3:101-109.
49. Olney JW, Wozniak DF, Farber NB (1997) Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies. Arch Neurol 54:1234-1240.
50. Irizarry MC, et al. (1997) Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 17:7053-7059.
51. Palop JJ, Mucke L (2009) Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66:435-440.
52. Zhang D, et al. (2009) Na,K-ATPase activity regulates AMPA receptor turnover through proteasome-mediated proteolysis. J Neurosci 29:4498-4511.
53. Hsieh H, et al. (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52:831-843.
54. Seipp S, Buselmaier W (1994) Isolation of glyceraldehyde 3-phosphate dehydrogenase (Gapdh) cDNA from the distal half of mouse chromosome 16: Further indication of a link between Alzheimer's disease and glycolysis. Neurosci Lett 182:91-94.
55. Li Y, et al. (2004) Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci USA 101:15688-15693.
56. Cumming RC, Schubert D (2005) Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J 19:2060-2062.
57. Cirrito JR, et al. (2008) Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58:42-51.
58. Cirrito JR, et al. (2005) Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48:913-922.
59. Kamenetz F, et al. (2003) APP processing and synaptic function. Neuron 37:925-937.
60. Plant LD, et al. (2006) Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current. Neurobiol Aging 27:1673-1683.
61. Puzzo D, et al. (2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28:14537-14545.
62. Lacor PN, et al. (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807.
63. Freir DB, et al. (2010) Abeta oligomers inhibit synapse remodelling necessary for memory consolidation. Neurobiol Aging, S0 197-4580(10)00030-8[pii] doi: 10:1016/j.neurobiolaging.2010.01.001.
64. Mattson MP, Magnus T (2006) Ageing and neuronal vulnerability. Nat Rev Neurosci 7:278-294.
65. Fukui H, Moraes CT (2008) The mitochondrial impairment, oxidative stress and neurodegeneration connection: Reality or just an attractive hypothesis? Trends Neurosci 31:251-256.
66. Mejías R, et al. (2006) Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice. J Neurosci 26:4500-4508.
67. Russell RL, et al. (1999) Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch Biochem Biophys 370:236-239.
68. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39:43-56. (Pubitemid 36830947)
69. Palmer AM (1999) The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease. J Neural Transm 106:317-328.
70. Vulliamy T, Mason P, Luzzatto L (1992) The molecular basis of glucose-6-phosphate dehydrogenase deficiency. Trends Genet 8:138-143.
71. Magistretti PJ (2006) Neuron-glia metabolic coupling and plasticity. J Exp Biol 209:2304-2311.
72. Herrero-Mendez A, et al. (2009) The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol 11:747-752.
73. Allaman I, et al. (2010) Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: Impact on neuronal viability. J Neurosci 30:3326-3338.
74. Allman J, Hakeem A, Watson K (2002) Two phylogenetic specializations in the human brain. Neuroscientist 8:335-346.
75. Craft S, et al. (1996) Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 17:123-130.
76. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43:2412-2414.
77. Snyder AZ (1996) Difference image vs ratio image error function forms in PET-PET realignment in quantification of brain function using PET. Quantification of Brain Function Using PET, eds Myer R, Cunningham VJ, Bailey DL, Jones T (Academic, San Diego), pp 131-137.
78. Fagan AM, et al. (2009) Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease. EMBO Mol Med 1:371-380.
79. Morris JC, et al. (2010) APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 67:122-131.